Literature DB >> 21081668

Cyclic AMP analog blocks kinase activation by stabilizing inactive conformation: conformational selection highlights a new concept in allosteric inhibitor design.

Suguna Badireddy1, Gao Yunfeng, Mark Ritchie, Pearl Akamine, Jian Wu, Choel W Kim, Susan S Taylor, Lin Qingsong, Kunchithapadam Swaminathan, Ganesh S Anand.   

Abstract

The regulatory (R) subunit of protein kinase A serves to modulate the activity of protein kinase A in a cAMP-dependent manner and exists in two distinct and structurally dissimilar, end point cAMP-bound "B" and C-subunit-bound "H"-conformations. Here we report mechanistic details of cAMP action as yet unknown through a unique approach combining x-ray crystallography with structural proteomics approaches, amide hydrogen/deuterium exchange and ion mobility mass spectrometry, applied to the study of a stereospecific cAMP phosphorothioate analog and antagonist((Rp)-cAMPS). X-ray crystallography shows cAMP-bound R-subunit in the B form but surprisingly the antagonist Rp-cAMPS-bound R-subunit crystallized in the H conformation, which was previously assumed to be induced only by C-subunit-binding. Apo R-subunit crystallized in the B form as well but amide exchange mass spectrometry showed large differences between apo, agonist and antagonist-bound states of the R-subunit. Further ion mobility reveals the apo R-subunit as an ensemble of multiple conformations with collisional cross-sectional areas spanning both the agonist and antagonist-bound states. Thus contrary to earlier studies that explained the basis for cAMP action through "induced fit" alone, we report evidence for conformational selection, where the ligand-free apo form of the R-subunit exists as an ensemble of both B and H conformations. Although cAMP preferentially binds the B conformation, Rp-cAMPS interestingly binds the H conformation. This reveals the unique importance of the equatorial oxygen of the cyclic phosphate in mediating conformational transitions from H to B forms highlighting a novel approach for rational structure-based drug design. Ideal inhibitors such as Rp-cAMPS are those that preferentially "select" inactive conformations of target proteins by satisfying all "binding" constraints alone without inducing conformational changes necessary for activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21081668      PMCID: PMC3047156          DOI: 10.1074/mcp.M110.004390

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  49 in total

1.  8-Substituted cAMP analogues reveal marked differences in adaptability, hydrogen bonding, and charge accommodation between homologous binding sites (AI/AII and BI/BII) in cAMP kinase I and II.

Authors:  F Schwede; A Christensen; S Liauw; T Hippe; R Kopperud; B Jastorff; S O Døskeland
Journal:  Biochemistry       Date:  2000-08-01       Impact factor: 3.162

2.  Classification and phylogenetic analysis of the cAMP-dependent protein kinase regulatory subunit family.

Authors:  Jaume M Canaves; Susan S Taylor
Journal:  J Mol Evol       Date:  2002-01       Impact factor: 2.395

3.  Automated protein model building combined with iterative structure refinement.

Authors:  A Perrakis; R Morris; V S Lamzin
Journal:  Nat Struct Biol       Date:  1999-05

Review 4.  The essential role of RI alpha in the maintenance of regulated PKA activity.

Authors:  Paul S Amieux; G Stanley McKnight
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

5.  A novel precursor ion discovery method on a hybrid quadrupole orthogonal acceleration time-of-flight (Q-TOF) mass spectrometer for studying protein phosphorylation.

Authors:  R H Bateman; R Carruthers; J B Hoyes; C Jones; J I Langridge; A Millar; J P C Vissers
Journal:  J Am Soc Mass Spectrom       Date:  2002-07       Impact factor: 3.109

6.  Consequences of cAMP-binding site mutations on the structural stability of the type I regulatory subunit of cAMP-dependent protein kinase.

Authors:  J M Cànaves; D A Leon; S S Taylor
Journal:  Biochemistry       Date:  2000-12-12       Impact factor: 3.162

7.  Amide H/2H exchange reveals communication between the cAMP and catalytic subunit-binding sites in the R(I)alpha subunit of protein kinase A.

Authors:  Ganesh S Anand; Carrie A Hughes; John M Jones; Susan S Taylor; Elizabeth A Komives
Journal:  J Mol Biol       Date:  2002-10-18       Impact factor: 5.469

8.  Differential binding of cAMP-dependent protein kinase regulatory subunit isoforms Ialpha and IIbeta to the catalytic subunit.

Authors:  X Cheng; C Phelps; S S Taylor
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

Review 9.  Cyclic nucleotide analogs as biochemical tools and prospective drugs.

Authors:  F Schwede; E Maronde; H Genieser; B Jastorff
Journal:  Pharmacol Ther       Date:  2000 Aug-Sep       Impact factor: 12.310

10.  Type II beta regulatory subunit of cAMP-dependent protein kinase: purification strategies to optimize crystallization.

Authors:  T C Diller; N H Xuong; S S Taylor
Journal:  Protein Expr Purif       Date:  2000-12       Impact factor: 1.650

View more
  33 in total

1.  Parallel Allostery by cAMP and PDE Coordinates Activation and Termination Phases in cAMP Signaling.

Authors:  Srinath Krishnamurthy; Nikhil Kumar Tulsian; Arun Chandramohan; Ganesh S Anand
Journal:  Biophys J       Date:  2015-08-11       Impact factor: 4.033

2.  Signaling through dynamic linkers as revealed by PKA.

Authors:  Madoka Akimoto; Rajeevan Selvaratnam; E Tyler McNicholl; Geeta Verma; Susan S Taylor; Giuseppe Melacini
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-14       Impact factor: 11.205

3.  Disrupting the Allosteric Interaction between the Plasmodium falciparum cAMP-dependent Kinase and Its Regulatory Subunit.

Authors:  Dene R Littler; Hayley E Bullen; Katherine L Harvey; Travis Beddoe; Brendan S Crabb; Jamie Rossjohn; Paul R Gilson
Journal:  J Biol Chem       Date:  2016-10-13       Impact factor: 5.157

4.  Neutron Crystallography Detects Differences in Protein Dynamics: Structure of the PKG II Cyclic Nucleotide Binding Domain in Complex with an Activator.

Authors:  Oksana Gerlits; James C Campbell; Matthew P Blakeley; Choel Kim; Andrey Kovalevsky
Journal:  Biochemistry       Date:  2018-03-13       Impact factor: 3.162

5.  Noncognate DNA damage prevents the formation of the active conformation of the Y-family DNA polymerases DinB and DNA polymerase κ.

Authors:  Philip Nevin; Xueguang Lu; Ke Zhang; John R Engen; Penny J Beuning
Journal:  FEBS J       Date:  2015-05-11       Impact factor: 5.542

6.  A substitution in cGMP-dependent protein kinase 1 associated with aortic disease induces an active conformation in the absence of cGMP.

Authors:  Matthew H Chan; Sahar Aminzai; Tingfei Hu; Amatya Taran; Sheng Li; Choel Kim; Renate B Pilz; Darren E Casteel
Journal:  J Biol Chem       Date:  2020-06-05       Impact factor: 5.157

7.  A novel allosteric site in casein kinase 2α discovered using combining bioinformatics and biochemistry methods.

Authors:  Hai-Ming Jiang; Jiang-Kai Dong; Kun Song; Tong-Dan Wang; Wen-Kang Huang; Jing-Miao Zhang; Xiu-Yan Yang; Ying Shen; Jian Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-07-27       Impact factor: 6.150

8.  Structures of the PKA RIα Holoenzyme with the FLHCC Driver J-PKAcα or Wild-Type PKAcα.

Authors:  Baohua Cao; Tsan-Wen Lu; Juliana A Martinez Fiesco; Michael Tomasini; Lixin Fan; Sanford M Simon; Susan S Taylor; Ping Zhang
Journal:  Structure       Date:  2019-03-21       Impact factor: 5.006

9.  A mechanism for the auto-inhibition of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel opening and its relief by cAMP.

Authors:  Madoka Akimoto; Zaiyong Zhang; Stephen Boulton; Rajeevan Selvaratnam; Bryan VanSchouwen; Melanie Gloyd; Eric A Accili; Oliver F Lange; Giuseppe Melacini
Journal:  J Biol Chem       Date:  2014-05-30       Impact factor: 5.157

10.  Active site coupling in PDE:PKA complexes promotes resetting of mammalian cAMP signaling.

Authors:  Srinath Krishnamurthy; Balakrishnan Shenbaga Moorthy; Lim Xin Xiang; Lim Xin Shan; Kavitha Bharatham; Nikhil Kumar Tulsian; Ivana Mihalek; Ganesh S Anand
Journal:  Biophys J       Date:  2014-09-16       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.